- China Natural Resources, Inc. (NASDAQ: CHNR) shares rose 60.2% to $2.74 in pre-market trading.
- Inuvo, Inc.. (NYSE: INUV) shares rose 42.9% to $0.9760 in pre-market trading.
- Inuvo, last week, priced a roughly 13.33 million share common stock offering at $0.60 per share.
- Ceragon Networks Ltd. (NASDAQ: CRNT) shares rose 41.2% to $6.85 in pre-market trading after jumping 54% on Friday. The company is expected to release Q4 earnings on February 8, 2021.
- Gevo, Inc. (NASDAQ: GEVO) rose 38.8% to $8.88 in pre-market trading. The company, last week, announced it had conceptualized new ‘Net-Zero Projects,’ through which it can produce energy-dense liquid hydrocarbons using renewable energy.
- ENDRA Life Sciences Inc. (NASDAQ: NDRA) rose 37.1% to $1.44 in pre-market trading. ENDRA Life Sciences, last week, was granted 13th US patent for its Taeus platform technology.
- DBV Technologies S.A. (NASDAQ: DBVT) rose 37.1% to $7.76 in pre-market trading. DBV Technologies shares jumped over 50% on Friday after the company issued an update on its investigational Viaskin peanut for children ages 4-11 years.
- Gritstone Oncology, Inc. (NASDAQ: GRTS) rose 35.2% to $8.64 in pre-market trading after the company advanced COVID-19 vaccine ‘CORAL’ program with support from the NIAID.
- Coherent, Inc. (NASDAQ: COHR) rose 31.7% to $200.11 in pre-market trading after Lumentum announced plans to acquire the company in a $5.7 billion cash and stock transaction.
- ObsEva SA (NASDAQ: OBSV) shares rose 26.5% to $5.15 in pre-market trading after jumping over 61% on Friday.
- Zomedica Corp. (NYSE: ZOM) rose 25.1% to $1.22 in pre-market trading. The company, last week, was granted international patent titled ‘Compositions And Methods For Diagnosing Urinary Tract Infections.’
- Triterras, Inc. (NASDAQ: TRIT) rose 22.3% to $9.88 in pre-market trading after declining around 25% on Friday.
- ShiftPixy, Inc. (NASDAQ: PIXY) shares rose 22.2% to $3.30 in pre-market trading. Morgan Stanley reported a 5.2% passive stake in Shiftpixy as of January 11, 2021.
- AMC Entertainment Holdings, Inc. (NYSE: AMC) shares rose 21.8% to $2.84 in pre-market trading after gaining around 7% on Friday.
- Lithium Americas Corp. (NYSE: LAC) rose 20.8% to $24.80 in pre-market trading. The U.S. Bureau of Land Management issued its final approval to the company’s Thacker Pass lithium project.
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) rose 20.8% to $9.46 in pre-market trading after climbing over 18% on Friday. The company’s Eye-Net Mobile subsidiary, last week, initiated a pilot project with a global Japanese vehicle manufacturer.
- Precision BioSciences, Inc. (NASDAQ: DTIL) rose 16.4% to $13.15 in pre-market trading after gaining over 8% on Friday.
- Ocugen, Inc. (NASDAQ: OCGN) rose 15.8% to $2.57 in pre-market trading.
- IZEA Worldwide, Inc. (NASDAQ: IZEA) rose 15.1% to $3.69 in pre-market trading. IZEA, last week, announced Hoozu joined the Influence+United alliance.
- Tellurian Inc. (NASDAQ: TELL) rose 15% to $2.45 in pre-market trading. Tellurian shares jumped over 25% on Friday after its co-founder and executive chairman Souki said the company is targeting to begin construction of its $16.8 billion Driftwood LNG export project in Louisiana by the summer of 2021.
- GameStop Corp. (NYSE: GME) shares rose 14.3% to $40.49 in pre-market trading after dropping around 11% on Friday.
- Purple Biotech Ltd. (NASDAQ: PPBT) rose 14.3% to $5.00 in pre-market trading.
- TransEnterix, Inc. (NYSE: TRXC) shares rose 13.5% to $2.35 in pre-market trading. TransEnterix, last week, announced a $31.25 million registered direct offering of common stock.
- EHang Holdings Limited (NASDAQ: EH) rose 12.5% to $45.00 in pre-market trading after dropping 10% on Friday.
- Metacrine, Inc. (NASDAQ: MTCR) rose 10.9% to $9.98 in pre-market trading as the company reported the FDA Fast Track designation for MET642 as a treatment of NASH.
Share this post:
Facebook
Twitter
LinkedIn
WhatsApp